Medical devices

BRUNCH

‘10% is nothing’: Singapore firms with US dealings soldier on, scale up despite Trump tariffs

Home-grown companies say the American market is as attractive as ever, even with import duties hurting margins

Abbott expects full-year adjusted earnings of US$5.38 to US$5.58 a share, against its previous forecast of US$5.55 to US$5.80.

Abbott cuts profit forecast in wake of cancer-screening deal

It still projects full-year 2026 comparable sales growth of 6.5% to 7.5%

The collaborations will “pave the way for patients, healthcare and industry practitioners in the respective markets to enjoy greater access to medicines, medical devices and other healthcare innovations”, says HSA.

HSA deepens pacts with Malaysia, Uzbekistan for faster medical innovation access

Singapore will also apply for full Medical Device Single Audit Program membership

LAC Med chief executive officer Liew Yoon Poh says: "Indonesia is compelling simply by sheer size, supported by its national health insurance scheme."

LAC Med set to list on Bursa with an AI healthcare play across Malaysia and Indonesia

Group’s proposed listing will serve as a springboard to accelerate regional expansion, with Indonesia as the sole overseas focus for now

Among the few listings on SGX that have done well this year are Centurion Accommodation Reit, Lum Chang Creations, and MetaOptics.
MARK TO MARKET

UltraGreen.ai right to move fast on Singapore listing instead of waiting for SGX-Nasdaq bridge

To drive its post-listing performance, the company should educate investors, lay out operational milestones and emphasise its competitive advantage

UltraGreen.ai shares are expected to list on the Singapore Exchange on Dec 3.

Surgical tech firm UltraGreen.ai files for US$377.1 million IPO on SGX mainboard

It is offering 112.1 million shares at US$1.45 or S$1.892 apiece; this includes 5.9 million shares for a retail tranche in Singapore

The advancements made by the joint research will enable Singapore companies to better serve clients in the aerospace and semiconductor sectors, among others.

Stronger, tougher, cleaner: A*Star and local companies find new solutions in advanced manufacturing

Three new joint labs will develop new capabilities for high-value sectors such as aerospace and semiconductors

“If the Asean market is where I’m going to see the largest growth, then I should be looking at potentially Asean as a place to be,” says UltraGreen co-CEO Ravinder Sajwan.

Surgical platform UltraGreen targets Asia for growth

Singapore is not being ruled out as a potential listing location as the company seeks to tap its largest market

China’s retaliatory tariff against US imports is already taking a toll on hospitals and drugmakers.

China asks drugmakers, hospitals to find US import substitutes

The tit-for-tat escalation has seen both sides ratchet up tariffs on each other’s goods to over 100 per cent, threatening to wipe out commerce between the world’s two largest economies